ID AMPPA_METVS Reviewed; 505 AA. AC A6URW3; DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot. DT 21-AUG-2007, sequence version 1. DT 27-MAR-2024, entry version 88. DE RecName: Full=AMP phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; DE Short=AMPpase {ECO:0000255|HAMAP-Rule:MF_02132}; DE EC=2.4.2.57 {ECO:0000255|HAMAP-Rule:MF_02132}; DE AltName: Full=Nucleoside monophosphate phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; DE Short=NMP phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; GN OrderedLocusNames=Mevan_1338; OS Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 OS / SB). OC Archaea; Euryarchaeota; Methanomada group; Methanococci; Methanococcales; OC Methanococcaceae; Methanococcus. OX NCBI_TaxID=406327; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB; RG US DOE Joint Genome Institute; RA Copeland A., Lucas S., Lapidus A., Barry K., Glavina del Rio T., Dalin E., RA Tice H., Pitluck S., Chain P., Malfatti S., Shin M., Vergez L., Schmutz J., RA Larimer F., Land M., Hauser L., Kyrpides N., Anderson I., RA Sieprawska-Lupa M., Whitman W.B., Richardson P.; RT "Complete sequence of Methanococcus vannielii SB."; RL Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Catalyzes the conversion of AMP and phosphate to adenine and CC ribose 1,5-bisphosphate (R15P). Exhibits phosphorylase activity toward CC CMP and UMP in addition to AMP. Functions in an archaeal AMP CC degradation pathway, together with R15P isomerase and RubisCO. CC {ECO:0000255|HAMAP-Rule:MF_02132}. CC -!- CATALYTIC ACTIVITY: CC Reaction=AMP + phosphate = adenine + alpha-D-ribose 1,5-bisphosphate; CC Xref=Rhea:RHEA:36975, ChEBI:CHEBI:16708, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:68688, ChEBI:CHEBI:456215; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CMP + phosphate = alpha-D-ribose 1,5-bisphosphate + cytosine; CC Xref=Rhea:RHEA:36987, ChEBI:CHEBI:16040, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:60377, ChEBI:CHEBI:68688; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- CATALYTIC ACTIVITY: CC Reaction=phosphate + UMP = alpha-D-ribose 1,5-bisphosphate + uracil; CC Xref=Rhea:RHEA:36991, ChEBI:CHEBI:17568, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57865, ChEBI:CHEBI:68688; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- SIMILARITY: Belongs to the thymidine/pyrimidine-nucleoside CC phosphorylase family. Type 2 subfamily. {ECO:0000255|HAMAP- CC Rule:MF_02132}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP000742; ABR55235.1; -; Genomic_DNA. DR RefSeq; WP_012066150.1; NC_009634.1. DR AlphaFoldDB; A6URW3; -. DR SMR; A6URW3; -. DR STRING; 406327.Mevan_1338; -. DR GeneID; 5325128; -. DR KEGG; mvn:Mevan_1338; -. DR eggNOG; arCOG02013; Archaea. DR HOGENOM; CLU_025040_6_0_2; -. DR OrthoDB; 9827at2157; -. DR Proteomes; UP000001107; Chromosome. DR GO; GO:0004645; F:1,4-alpha-oligoglucan phosphorylase activity; IEA:InterPro. DR GO; GO:0016208; F:AMP binding; IEA:UniProtKB-UniRule. DR GO; GO:0016763; F:pentosyltransferase activity; IEA:UniProtKB-UniRule. DR GO; GO:0006196; P:AMP catabolic process; IEA:UniProtKB-UniRule. DR GO; GO:0046125; P:pyrimidine deoxyribonucleoside metabolic process; IEA:InterPro. DR GO; GO:0006206; P:pyrimidine nucleobase metabolic process; IEA:InterPro. DR Gene3D; 1.20.970.50; -; 1. DR Gene3D; 2.40.40.20; -; 1. DR Gene3D; 3.40.1030.10; Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain; 1. DR Gene3D; 3.90.1170.30; Pyrimidine nucleoside phosphorylase-like, C-terminal domain; 1. DR HAMAP; MF_02132; AMP_phosphorylase; 1. DR InterPro; IPR017713; AMP_phosphorylase. DR InterPro; IPR000312; Glycosyl_Trfase_fam3. DR InterPro; IPR017459; Glycosyl_Trfase_fam3_N_dom. DR InterPro; IPR036320; Glycosyl_Trfase_fam3_N_dom_sf. DR InterPro; IPR035902; Nuc_phospho_transferase. DR InterPro; IPR036566; PYNP-like_C_sf. DR InterPro; IPR013102; PYNP_C. DR InterPro; IPR017872; Pyrmidine_PPase_CS. DR InterPro; IPR013466; Thymidine/AMP_Pase. DR InterPro; IPR000053; Thymidine/pyrmidine_PPase. DR NCBIfam; TIGR03327; AMP_phos; 1. DR NCBIfam; TIGR02645; ARCH_P_rylase; 1. DR PANTHER; PTHR10515; THYMIDINE PHOSPHORYLASE; 1. DR PANTHER; PTHR10515:SF0; THYMIDINE PHOSPHORYLASE; 1. DR Pfam; PF02885; Glycos_trans_3N; 1. DR Pfam; PF00591; Glycos_transf_3; 1. DR Pfam; PF07831; PYNP_C; 1. DR PIRSF; PIRSF000478; TP_PyNP; 1. DR SMART; SM00941; PYNP_C; 1. DR SUPFAM; SSF52418; Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain; 1. DR SUPFAM; SSF47648; Nucleoside phosphorylase/phosphoribosyltransferase N-terminal domain; 1. DR SUPFAM; SSF54680; Pyrimidine nucleoside phosphorylase C-terminal domain; 1. DR PROSITE; PS00647; THYMID_PHOSPHORYLASE; 1. PE 3: Inferred from homology; KW Glycosyltransferase; Transferase. FT CHAIN 1..505 FT /note="AMP phosphorylase" FT /id="PRO_0000314725" FT ACT_SITE 258 FT /note="Proton donor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 170 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 196..201 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 205 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 266 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 290 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" SQ SEQUENCE 505 AA; 54620 MW; 4D915C86528E1F02 CRC64; MLFLNAKFID LDLGANAVIV NEEDLKGTSY YPQDRVLIES HSGSVLGILY STKTMVQKGE VGIPVRKMKG ISLKEGEEVN LRHAEKPESI QFIKKKMDGQ VLSPNEIRTI IDEIVSKKLS NIELAAFVTS TYVNGMNMEE IVEMTKRMAE TGDMISWEKS LVVDIHSIGG VPGNKYALLS IPILAAAGIT IPKTSSRAIT SPAGTADVME VLTNVELDEE ELKRVVKATN GCLVWGGGVN LAPADDIIIN VERPVSIDPQ PQLLASVMAK KVATGIKYAV IDIPVGKGVK IKNEAEGAKL ARKFIELGEL LNIRVECVLT YGGQPLGRAI GPALEAKEAL EALTDPKSAP KSLIEKAISL AGILLELGGS AQIGDGQKLA WEILESGRAL EKFNQIIVEQ GGTPKKPEEI ELGKYVEEVR SPIDGYIVGI NNTSITNVVK EAGAPRDKKA GLLLNAKIGN KVKRGDILYT IYSGSEERLN SAVNLARRVY PVNVEGMMIE RISKF //